» Articles » PMID: 2477254

Major Histocompatibility Complex--dependent T Cell Epitopes of Lymphocytic Choriomeningitis Virus Nucleoprotein and Their Protective Capacity Against Viral Disease

Overview
Journal Eur J Immunol
Date 1989 Sep 1
PMID 2477254
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

In mice the immune response to infection with lymphocytic choriomeningitis virus (LCMV), a member of the arenavirus family, is mainly based on the activity of cytotoxic T cells. The immunogenic epitopes of the viral nucleoprotein recognized by cytotoxic T cells in various inbred strains of mice were defined. These epitopes were located in H-2d and H-2q mice in the amino-terminal region and in H-2b mice in the carboxy-terminal region of the nucleoprotein. A detailed analysis with synthetic peptides allowed the definition of a common epitope of 9 amino acids in H-2d and H-2q mice and of about 15 amino acids in H-2b mice. These T cell epitopes were all recognized in association with H-2 D or L transplantation antigen. The protective capacity of recombinant vaccinia viruses expressing these epitopes was documented by assaying prevention of virus replication, protection against LCM and prevention of the local footpad swelling reaction. Thus, distinct T cell epitopes on the same internal viral protein mediate protection in a major histocompatibility complex-restricted manner.

Citing Articles

The Significant Role of PA28αβ in CD8 T Cell-Mediated Graft Rejection Contrasts with Its Negligible Impact on the Generation of MHC-I Ligands.

Inholz K, Bader U, Mundt S, Basler M Int J Mol Sci. 2024; 25(11).

PMID: 38891837 PMC: 11172216. DOI: 10.3390/ijms25115649.


Chikungunya Virus Evades Antiviral CD8 T Cell Responses To Establish Persistent Infection in Joint-Associated Tissues.

Davenport B, Bullock C, McCarthy M, Hawman D, Murphy K, Kedl R J Virol. 2020; 94(9).

PMID: 32102875 PMC: 7163133. DOI: 10.1128/JVI.02036-19.


Stable antigen is most effective for eliciting CD8+ T-cell responses after DNA vaccination and infection with recombinant vaccinia virus in vivo.

Schliehe C, Bitzer A, van den Broek M, Groettrup M J Virol. 2012; 86(18):9782-93.

PMID: 22761378 PMC: 3446605. DOI: 10.1128/JVI.00694-12.


A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.

Shedlock D, Talbott K, Cress C, Ferraro B, Tuyishme S, Mallilankaraman K Vaccine. 2011; 29(39):6755-62.

PMID: 21238574 PMC: 3167034. DOI: 10.1016/j.vaccine.2010.12.064.


Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Dow C, Oseroff C, Peters B, Nance-Sotelo C, Sidney J, Buchmeier M J Virol. 2008; 82(23):11734-41.

PMID: 18829752 PMC: 2583689. DOI: 10.1128/JVI.00435-08.